T Rowe Price Group Inc/ US74144T1088 /
31.05.2024 22:00:00 | Изменение +2.2800 | Объем сделки | Бид0:58:29 | Предложение0:58:29 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
117.8300USD | +1.97% | 2.67 млн Оборот: 214.78 млн |
117.8300Величина цены спроса: 100 | 120.0000Величина цены предложения: 500 | 26.31 млрдUSD | 4.14% | 15.15 |
GlobeNewswire
23:07
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
18:30
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
17:31
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
16:55
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
16:00
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
16:00
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
16:00
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
15:51
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
15:01
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
GlobeNewswire
14:56
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница